
Join to view full profile
52 Bailey DriveWashington Crossing, PA 18977
Dr. Cohen is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Fredric Cohen, MD, based in Washington Crossing, PA, specializes in pharmaceutical development. He completed his Endocrinology fellowship at the NIH Clinical Center between 1993 and 1995 and his Internal Medicine residency at Wake Forest University Baptist Medical Center from 1990 to 1993. Dr. Cohen graduated from Pennsylvania State University College of Medicine in 1990. His professional training included serving as a fellow at the NIH Clinical Center and a resident physician at Atrium Health Wake Forest Baptist. As a medical leader in the biopharmaceutical industry, he has led successful therapeutic and diagnostic programs across various areas of internal medicine and neurology. He currently is a consultant to industry.
Education & Training
National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1993 - 1995
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1990 - 1993
Pennsylvania State University College of MedicineClass of 1990
Certifications & Licensure
PA State Medical License 2000 - 2016
Clinical Trials
Publications & Presentations
PubMed
- 18 citationsLevoketoconazole in the Treatment of Patients With Cushing's Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study.Rosario Pivonello, Atanaska Elenkova, Maria Fleseriu, Richard A Feelders, Przemysław Witek
Frontiers in Endocrinology. 2021-04-07 - 17 citationsLevoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing’s syndromeEliza B Geer, Roberto Salvatori, Atanaska Elenkova, Maria Fleseriu, Rosario Pivonello
Pituitary. 2021-02-01 - 2 citationsCorrection to: Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome.Eliza B Geer, Roberto Salvatori, Atanaska Elenkova, Maria Fleseriu, Rosario Pivonello
Pituitary. 2021-02-01
Professional Memberships
- Member
Industry Relationships
- Vice President, Clinical Research and Development, Strongbridge Biopharma2015 - Present
External Links
- Websitehttp://www.strongbridgebio.com
- LinkedInhttps://www.linkedin.com/in/pharmagrowth
- Research Gatehttps://www.researchgate.net/profile/Fj_Cohen
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









